{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:07:03Z","timestamp":1790165223564,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000982","name":"Conquer Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.rpth.2026.106830","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:06:54Z","timestamp":1784045214000},"page":"106830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal validation of the electronic health record cancer-associated thrombosis model in patients with low bleeding risk"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2266-0221","authenticated-orcid":false,"given":"Jennifer","family":"La","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaelyn","family":"Nannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhan V.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary T.","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael R.","family":"Fillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-2309","authenticated-orcid":false,"given":"Ang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106830_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2026.106830_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106830_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: Burden, mechanisms, and management","volume":"117","author":"Ay","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106830_bib4","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"S\u00f8rensen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106830_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106830_bib6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106830_bib7","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1200\/JCO.22.01542","article-title":"Derivation and validation of a clinical risk assessment model for cancer-associated thrombosis in two unique US health care systems","volume":"41","author":"Li","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpth.2026.106830_bib8","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106830_bib9","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/jth.15503","article-title":"Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer","volume":"19","author":"Guman","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106830_bib10","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106830_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102650","article-title":"External validation of a novel cancer-associated venous thromboembolism risk assessment score in a safety-net hospital","volume":"9","author":"Dulberger","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106830_bib12","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ajh.27335","article-title":"Thrombosis risk prediction in lymphoma patients: a multi-institutional, retrospective model development and validation study","volume":"99","author":"Ma","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2026.106830_bib13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/ajh.26928","article-title":"External validation of a novel electronic risk score for cancer-associated thrombosis in a comprehensive cancer center","volume":"98","author":"Li","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2026.106830_bib14","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/ajh.26954","article-title":"Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy","volume":"98","author":"Li","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2026.106830_bib15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jtha.2024.10.021","article-title":"Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study","volume":"23","author":"Lanting","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106830_bib16","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1182\/bloodadvances.2025016044","article-title":"Validation of risk assessment models for venous thromboembolism in patients with cancer receiving systemic therapies","volume":"9","author":"Vladi\u0107","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106830_bib17","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.jtha.2025.07.021","article-title":"Development and validation of venous thromboembolism-bidirectional encoder representations from transformers (VTE-BERT) natural language processing model","volume":"24","author":"Jafari","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106830_bib18","author":"Heagerty"},{"key":"10.1016\/j.rpth.2026.106830_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.44428","article-title":"Validation of a risk score for cancer-associated thrombosis using nationwide EHR data","volume":"8","author":"Li","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rpth.2026.106830_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7205\/MILMED-D-11-00434","article-title":"Cancer incidence among patients of the U.S. Veterans Affairs Health Care System","volume":"177","author":"Zullig","year":"2012","journal-title":"Mil Med"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926034886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926034886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:51:38Z","timestamp":1790164298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926034886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2475037926034886"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106830","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal validation of the electronic health record cancer-associated thrombosis model in patients with low bleeding risk","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106830"}}